Evidence map›Paper›PMID 39397777›Full record

ReviewEuropean heart journal2024

Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing.

Jacqueline Joza, Haran Burri, Jason G Andrade, Dominik Linz, Kenneth A Ellenbogen, Kevin Vernooy

Registry-linked trialAbstract readReview
In one paragraph

Review in European heart journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07604727 (AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07604727 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation: The APAF-CSP All-cause Mortality and Quality of Life Trial

TypeinterventionalSponsorUniversity Medical Center GroningenRan2026 to 2030Enrolled292ConditionsAtrial Fibrillation (AF), Heart Failure, Cardiac PacingArmsConduction System Pacing, Cardiac resynchronization therapy
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Conduction system pacing for cardiac resynchronization therapy: a systematic review.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Review
  3. Procedural Management of Atrial Fibrillation in Older Patients.Reviews in cardiovascular medicine · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Long-term outcomes of pace-and-ablate strategy in patients with atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome.Journal of the American Society of Nephrology : JASN · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jacqueline JozaDepartment of Medicine, McGill University Health Center, Montreal, Quebec, Canada.ORCID 0000-0003-0956-688X
Haran BurriCardiology Department, University Hospital of Geneva, Geneva, Switzerland.
Jason G AndradeDepartment of Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.ORCID 0000-0002-8493-5123
Dominik LinzDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0003-4893-0824
Kenneth A EllenbogenVirginia Commonwealth University Medical Center, Richmond, VA, USA.ORCID 0000-0002-8527-569X
Kevin VernooyDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0002-8818-5964

Funding

Fonds de Recherche du Quebec Santé
6 · The paper itself

Abstract

Despite key advances in catheter-based treatments, the management of persistent atrial fibrillation (AF) remains a therapeutic challenge in a significant subset of patients. While success rates have improved with repeat AF ablation procedures and the concurrent use of antiarrhythmic drugs, the likelihood of maintaining sinus rhythm during long-term follow-up is still limited. Atrioventricular node ablation (AVNA) has returned as a valuable treatment option given the recent developments in cardiac pacing. With the advent of conduction system pacing, AVNA has seen a revival where pacing-induced cardiomyopathy after AVNA is felt to be overcome. This review will discuss the role of permanent pacemaker implantation and AVNA for AF management in this new era of conduction system pacing. Specifically, this review will discuss the haemodynamic consequences of AF and the mechanisms through which 'pace-and-ablate therapy' enhances outcomes, analyse historical and more recent literature across various pacing methods, and work to identify patient groups that may benefit from earlier implementation of this approach.

Indexed as

Atrial FibrillationAtrioventricular NodeCardiac Pacing, ArtificialCatheter AblationHumansPacemaker, ArtificialTreatment OutcomeAtrial fibrillationAtrioventricular node ablationCatheter ablationConduction system pacing

Identifiers

PMID39397777
PMCPMC11631063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.